CAPTRUST FINANCIAL ADVISORS - ZENTALIS PHARMACEUTICALS INC ownership

ZENTALIS PHARMACEUTICALS INC's ticker is ZNTL and the CUSIP is 98943L107. A total of 95 filers reported holding ZENTALIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
CAPTRUST FINANCIAL ADVISORS ownership history of ZENTALIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$21,000
-40.0%
750
-1.7%
0.00%
Q1 2022$35,000763
+15160.0%
0.00%
Q4 2021$0
-100.0%
5
-98.7%
0.00%
Q4 2020$20,0003850.00%
Other shareholders
ZENTALIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Mayo Clinic 362,459$15,727,096,00018.11%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2,664,409$115,609,0002.54%
Matrix Capital Management Company, LP 3,821,739$165,825,0001.92%
Avidity Partners Management LP 1,263,300$54,815,0001.51%
Redmile Group, LLC 2,221,044$96,371,0001.36%
Affinity Asset Advisors, LLC 77,500$3,363,0001.14%
SPHERA FUNDS MANAGEMENT LTD. 175,140$7,599,0000.58%
Eventide Asset Management 832,000$36,100,0000.54%
Integral Health Asset Management, LLC 40,000$1,736,0000.50%
VIKING GLOBAL INVESTORS LP 2,399,284$104,105,0000.31%
View complete list of ZENTALIS PHARMACEUTICALS INC shareholders